Conversant Bio Releases a New Definitive Guide to Oncology Blood Uses in Cancer Research
New E-book Reveals Why Oncology Blood Opens Up Possibilities to Advance Cancer Research
(firmenpresse) - HUNTSVILLE, AL -- (Marketwired) -- 11/13/13 -- Conversant Bio, a global leader in supplying the highest quality human tissue and viable cell samples, today announced it is issuing a new E-book focusing on the specific uses and importance of using blood samples in oncology research. The resource, The Definitive Guide to Oncology Blood Uses in Cancer Research, is available for free download on the company's website at:
Most of cancer research revolves around identifying and understanding the molecular and cellular makeup of cancer cells and how they behave differently from normal cells. High quality human biospecimens are an important part of this work. However, advancing not only requires tissues, but also biofluids such as blood.
In its newest E-book, Conversant Bio explains the five specific uses of blood in oncology research, and shares the key criteria researchers should look for when purchasing oncology blood for their studies. In addition, the E-book shares an overview of biomarker use in cancer medicine, dives into the use of and uncovers the benefits of personalized medicine in cancer treatment.
"It's important for researchers to know that oncology blood opens up the possibility to advance their cancer research through sample specificity and flexibility," says Luke Dorion, Chief Commercial Officer for Conversant Bio. "Our goal with this E-book was to share crucial information about the uses and importance for oncology blood, so we can help scientists optimize their clinical trials and meet their cancer research goals."
For additional information about this new E-book or Conversant Bio's services, please visit the company's website at
Conversant Bio provides researchers around the world with hyper-annotated tissue samples in order to conduct informed, cutting edge investigations into many of today's most problematic diseases. With a large prospective collections network of 36 U.S. based clinical sites, and an IRB reviewed chain of custody Quality Control System, Conversant Bio provides you with the highest quality samples on time, and on budget. For additional information about Conversant Bio's services, please visit the company's website at
Image Available:
Luke Doiron
Chief Commercial Officer
(866) 838-2798
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.11.2013 - 10:00 Uhr
Sprache: Deutsch
News-ID 1282788
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
HUNTSVILLE, AL
Phone:
Kategorie:
Drugs
Anmerkungen:
Diese Pressemitteilung wurde bisher 148 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Conversant Bio Releases a New Definitive Guide to Oncology Blood Uses in Cancer Research
"
steht unter der journalistisch-redaktionellen Verantwortung von
Conversant Bio (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
